Schonfeld Strategic Advisors’s Audentes Therapeutics, Inc BOLD Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,200	Closed	-$491K	–	1703
2019 Q4	$491K	Buy	+8,200	New	+$308K	0.01%	752
2019 Q2	–	Sell	-19,300	Closed	-$753K	–	1372
2019 Q1	$753K	Sell	19,300 -31,400	-62%	-$900K	0.03%	583
2018 Q4	$1.08M	Buy	+50,700	New	+$1.31M	0.04%	464

Schonfeld Strategic Advisors's BOLD Position: Q1 2020 in Review

Schonfeld Strategic Advisors sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 8,200 shares — an estimated $491K sold.

Schonfeld Strategic Advisors first reported a position in BOLD in Q4 2018 and held it in 3 quarters. The position peaked at $1.08M in Q4 2018. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Schonfeld Strategic Advisors reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Schonfeld Strategic Advisors sold 8,200 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $491K.
Schonfeld Strategic Advisors first reported a position in Audentes Therapeutics, Inc in Q4 2018 and held it in 3 quarters.
Schonfeld Strategic Advisors's Audentes Therapeutics, Inc position peaked at $1.08M in Q4 2018.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2020, filed 15 May 2020.